Blepharitis Clinical Trial
Official title:
A Single-Center, Open-Label, Randomized Pilot Study of the Safety and Efficacy of AzaSite® Ophthalmic Solution, 1% in Combination With Mechanical Therapy Versus Mechanical Therapy Alone for Four Weeks in Subjects With Posterior Blepharitis
The purpose of this study is to evaluate the safety and efficacy of AzaSite® ophthalmic solution, 1% on signs and symptoms of blepharitis.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04475432 -
Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis
|
Phase 2/Phase 3 | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT05629390 -
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA Study
|
Phase 3 | |
Terminated |
NCT02938078 -
Ocular Comfort and Inflammation in Lid Hygiene Therapy
|
N/A | |
Completed |
NCT01408082 -
Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis
|
Phase 3 | |
Completed |
NCT01028027 -
Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivitis
|
Phase 3 | |
Recruiting |
NCT04858113 -
Short-term Effects on Tear Film (Baby Shampoo vs Blephasol)
|
N/A | |
Completed |
NCT00560703 -
Treatment of Patients With Blepharitis and Facial Rosacea
|
Phase 2 | |
Recruiting |
NCT02455895 -
Efficacy of iLid Cleanser (Avenova) Versus Vehicle on Ocular Skin Flora
|
N/A | |
Completed |
NCT00894530 -
The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)
|
Phase 2 | |
Completed |
NCT01115192 -
Blephacura Versus Baby Shampoo to Treat Blepharitis
|
N/A | |
Completed |
NCT02386774 -
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa
|
N/A | |
Completed |
NCT01808560 -
Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
|
N/A | |
Completed |
NCT01089608 -
Efficacy and Safety Assessment of Azyter® Eye Drops (T1225) in Patients With Blepharitis
|
Phase 2 | |
Completed |
NCT00629941 -
Safety and Efficacy Study of AzaSite® in Subjects With Blepharitis
|
Phase 4 | |
Completed |
NCT00629590 -
Safety and Efficacy Pilot Study of AzaSite (Azithromycin) in Subjects With Blepharitis
|
Phase 4 | |
Completed |
NCT03926026 -
Study Evaluating the Safety and Tolerability of NCX 4251 for the Treatment of Acute Exacerbations of Blepharitis
|
Phase 2 | |
Recruiting |
NCT04603222 -
Evaluation of SUMMIT BRUSH in Treatment of Blepharitis
|
N/A | |
Completed |
NCT02218489 -
Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease
|
Phase 2 | |
Completed |
NCT00796926 -
Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes
|
Phase 3 |